Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Salute | Prodotti farmaceutici | 6,40 Mrd € | 45x | 0,14 | 7,74 € | -2,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Grifols | Madrid | Salute | Prodotti farmaceutici | 6,40 Mrd € | 45x | 0,14 | 10,42 € | -2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Laborat.Rovi | Madrid | Salute | Prodotti farmaceutici | 2,75 Mrd € | 20x | -1,22 | 53,80 € | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 42,8% Rialzo | Fai l’upgrade a Pro+ | |
Almirall | Madrid | Salute | Prodotti farmaceutici | 2,13 Mrd € | 206,8x | 1,66 | 9,95 € | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17% Rialzo | Fai l’upgrade a Pro+ | |
Pharma Mar | Madrid | Salute | Prodotti farmaceutici | 1,67 Mrd € | -958,5x | 96,15 € | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,2% Ribasso | Fai l’upgrade a Pro+ | ||
Faes Farma | Madrid | Salute | Prodotti farmaceutici | 1,08 Mrd € | 11,1x | 3,46 € | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,8% Rialzo | Fai l’upgrade a Pro+ | ||
Natac Natural Ingredients | Madrid | Salute | Prodotti farmaceutici | 282,63 Mln € | -41,6x | 0,65 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Laboratorio Reig Jofre | Madrid | Salute | Prodotti farmaceutici | 206,55 Mln € | 22x | 2,58 € | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Labiana Health | Madrid | Salute | Prodotti farmaceutici | 20,42 Mln € | -16,4x | -0,2 | 2,90 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -17,2% Ribasso | Fai l’upgrade a Pro+ |